Fingerprint
Dive into the research topics of 'Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: A phase II southwest oncology group study (S0415)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically